pharmaphorum2d
Mylan launches Advair generic at 70% discount in US
The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016. But Mylan became the first of a group of potential ...
‘They tried home remedies’: Mom let 9-year-old daughter die from asthma attack, gave her a ‘steam bath’ instead of taking her to the hospital
A mom in Minnesota is heading to prison for causing the death of her daughter after she refused to let the parents of one of ...
pharmaphorum5d
Teva launches digital asthma and COPD rescue inhaler in US
Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).
Medscape3d
Short-Term Safety and Tolerability of Double-Dose Salmeterol/Fluticasone Propionate in Adult Asthmatic Patients
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... daily from a Diskus™ inhaler for a 4-week run ...
Medscape6d
The Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome
Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...